Matthew Menza

Johnson University — United States

Medicine · Health Sciences

38h-index6.2kcitations96works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(43), Neurological disorders and treatments(24), Autism Spectrum Disorder Research(14), Treatment of Major Depression(12), Schizophrenia research and treatment(10)

Publications96 total

Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha‐Synuclein Seed Amplification Assay
Movement Disorders·2026Open Access
The Impact of Antidepressant Treatment on Cognitive Functioning in Depressed Patients with Parkinson’s Disease
UNC Libraries·2020Open Access
Telephone-based cognitive behavioral therapy for depression in Parkinson disease
Neurology·2020· 114 citedOpen Access
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson’s disease psychosis: an expert consensus
CNS Spectrums·2019· 1 citedOpen Access
Cognitive behavioral therapy improves diverse profiles of depressive symptoms in Parkinson's disease
International Journal of Geriatric Psychiatry·2019· 30 cited
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson’s disease psychosis: an expert consensus
CNS Spectrums·2018· 16 citedOpen Access
Personalized Telemedicine for Depression in Parkinson’s Disease: A Pilot Trial
Journal of Geriatric Psychiatry and Neurology·2018· 38 cited
Update on the Management of Parkinson's Disease: Focus on Psychosis
The Consultant Pharmacist·2016
163. Inflammation and post-stroke depression: Preliminary progress
Brain Behavior and Immunity·2014· 3 cited
Littoral Combat Ship Open Ocean Anti-Submarine Warfare
2014Open Access
Neuropsychological Outcomes After Psychosocial Intervention for Depression in Parkinson’s Disease
Journal of Neuropsychiatry·2013· 19 citedOpen Access
Barriers to Mental Health Care Utilization in Parkinson’s Disease
Journal of Geriatric Psychiatry and Neurology·2013· 89 citedOpen Access
Barriers Survey
PsycTESTS Dataset·2013
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
Neurology·2012· 329 citedOpen Access
Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's disease.
Journal of Consulting and Clinical Psychology·2012· 62 citedOpen Access
Telephone-Based Cognitive–Behavioral Therapy for Depression in Parkinson Disease
Journal of Geriatric Psychiatry and Neurology·2011· 88 citedOpen Access
Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
American Journal of Psychiatry·2011· 293 cited
The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson’s Disease
Psychosomatics·2010· 159 citedOpen Access
Depression in Parkinson's Disease: Symptom Improvement and Residual Symptoms After Acute Pharmacologic Management
American Journal of Geriatric Psychiatry·2010· 42 cited
Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placebo
Movement Disorders·2010· 108 cited
page 1 of 5Next →

Frequent Co-authors

Roseanne D. Dobkin(23), Michael A. Gara(16), Humberto Marín(14), Karina Bienfait(13), Lesley A. Allen(10), Margery H. Mark(10), Allison Dicke(6), Jill Harkavy‐Friedman(5), Raymond C. Rosen(4), M. H. Mark(3), Jade Tiu(3), Lawrence I. Golbe(3), Ronald Cody(3), Nancy Forman(3), Alejandro Interian(3), Steven Buyske(2), Roger Kurlan(2), Jeffrey M. Lyness(2), Peter G. Como(2), N. Shirlene Pearson(2)